Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2
{{output}}
Sodium glucose cotransporter 2 inhibitors (SGLT2i) constitute the only medication class that consistently prevents or attenuates human heart failure (HF) independent of ejection fraction. We have suggested earlier that the protective mechanisms of the SGLT2i E... ...
